240 Per Cent Returns: Multibagger Auto Component Manufacturer Reports Strong Q4 Results; PAT Jumps 13 Per Cent 240 Per Cent Returns: Multibagger Auto Component Manufacturer Reports Strong Q4 Results; PAT Jumps 13 Per Cent Company's revenue surged 14 per cent YoY to Rs 2,136.06 crore, up from Rs 1,874.55 crore in the same quarter last year. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 2.0 The EBITDA rose 14 per cent YoY to Rs 370.4 crore, compared to Rs 324.1 crore in Q4 CY23.
Smallcap Company Reports 157 Per Cent EBITDA Growth Despite Revenue Decline Smallcap Company Reports 157 Per Cent EBITDA Growth Despite Revenue Decline The company’s revenue declined 10 per cent year-on-year (YoY) to Rs 3,675.7 crore, compared to Rs 4,100.6 crore in Q4 CY23. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 4.2 Company is a leading vertically integrated manufacturer of carbon, cement, and advanced materials.
From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump From Wall Street to Dalal Street, Bears Rule Amid U.S. Consumer Confidence Slump After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why! DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 5.0 After plunging 15-16 per cent from its record highs, the Nifty 50 is now approaching the 22,000 level, marked by a significant red candle today. Here's why!
350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent 350 Per Cent Returns: Water Theme Company Reports 33 Per Cent PAT Growth, Sales Up 21 Per Cent Net profit witnessed a 33 per cent YoY increase, reaching Rs 73.1 crore, compared to Rs 54.9 crore in Q4 CY23. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 4.1 Over the last five years, the stock has delivered an impressive return of 352.55 per cent. The company’s current market capitalization stands at Rs 10,603 crore.
Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 4.3 With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.
Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years. DSIJ Intelligence-1 / Friday, February 28, 2025 / Article rating: 3.7 The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years.
Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent. DSIJ Intelligence-1 / Friday, February 28, 2025 / Article rating: 3.1 The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent.
UPI 3.0 – What’s Next for India’s Digital Payments Revolution? UPI 3.0 – What’s Next for India’s Digital Payments Revolution? How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 3.9 How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access
Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 5.0 Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.
Market Crash: Sensex & Nifty Down Over 1.8 Per Cent, Midcap & Smallcap Indices Plunge Upto 2.5 Per Cent Market Crash: Sensex & Nifty Down Over 1.8 Per Cent, Midcap & Smallcap Indices Plunge Upto 2.5 Per Cent The Nifty 50 closed down by 1.86 per cent to 22,124.70, and the Sensex fell by 1.90 per cent to 73,198.10. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 1.0 Market breadth was extremely negative, with 489 advances and 2,416 declines, indicating a severe negative sentiment prevailing among investors.